Bond LifePoint Health 9.75% ( USU53039AE01 ) in USD

Issuer	LifePoint Health
Market price	100 % ▼
Country	United States
ISIN code	USU53039AE01 ( in USD )
Interest rate	9.75% per year ( payment 2 times a year)
Maturity	01/12/2026
Prospectus brochure in PDF format
Minimal amount	2 000 USD
Total amount	1 425 000 000 USD
Cusip	U53039AE0
Standard & Poor's ( S&P ) rating	CCC+ ( Substantial risks )
Moody's rating	N/A
Next Coupon	01/12/2026 ( In 114 days )
Detailed description	LifePoint Health is a large US-based healthcare company that operates hospitals and other healthcare facilities across various states, providing a range of medical services. LifePoint Health Bond (ISIN: USU53039AE01) ? A Comprehensive Financial Overview This report provides an in-depth analysis of a significant fixed-income instrument issued by LifePoint Health. Identified by its ISIN USU53039AE01 and CUSIP U53039AE0, this bond represents a notable offering within the U.S. debt markets. LifePoint Health, the issuer of this bond, is a prominent healthcare company operating across the United States. As a diversified healthcare provider, LifePoint Health is known for its network of hospitals, healthcare facilities, and related services, playing a vital role in delivering patient care in various communities. Its operations span a wide range of medical specialties and regions within the U.S. healthcare landscape. The bond, issued in the United States and denominated in US Dollars (USD), is currently trading at par value, with a market price of 100%. Investors are attracted by a substantial annual interest rate of 9.75%, which offers a competitive yield in the current market environment. Interest payments for this security are structured to occur semi-annually, providing regular cash flows to bondholders. With a maturity date set for December 1, 2026, this bond offers a medium-term investment horizon. The total size of the bond issuance is considerable, amounting to $1,425,000,000, indicating a significant capital raise by LifePoint Health. For potential investors, the minimum purchase threshold is set at $2,000, making it accessible to a range of institutional and qualified individual investors. A crucial aspect for risk assessment is the bond's credit rating; it holds a CCC+ rating from Standard & Poor's (S&P), which signals a higher level of credit risk and suggests that the bond is speculative with a material risk of default, though it also reflects the higher coupon offered.